1MW MFE220 Factory Acceptance Test update
Clean Power Hydrogen plc has requested a suspension of its shares from trading on AIM due to significant damage to its MFE220 1MW unit during a Factory Acceptance Test, which has materially delayed its completion and caused a constrained working capital position. The company is actively evaluating funding and strategic options to address immediate liquidity requirements and is reviewing its insurance and commercial arrangements. Discussions regarding a potential equity capital raise have been paused pending greater technical clarity following the incident.
Select text to share a quote on X · sign in to keep highlights & notes in your CPH2 notes
596/2014 which is part of UK law by virtue of the European Union (withdrawal) Act 2018.
Clean Power Hydrogen plc
("CPH2" or the "Company")
1MW MFE220 Factory Acceptance Test update
Clean Power Hydrogen plc (AIM:CPH2), the developer of market disrupting and IP-protected Membrane-Free Electrolyser ("MFE") technology for the co-production of high purity hydrogen and above medical-grade purity oxygen, provides an update on the third and final Factory Acceptance Test ("FAT") of its MFE220 1MW unit.
In the final stages of testing at the Company's dedicated and secure test site facility in Rossington, near Doncaster, the unit experienced an unexpected error, causing it to commence a standard shutdown procedure. During that shutdown procedure, the unit experienced an incident which has caused significant damage to the equipment. In line with the Company's health, safety and environmental protection processes, all operations have been suspended and a thorough investigation is underway into the causes of the original error and the subsequent failure.
This unfortunate incident will materially delay successful completion of the FAT for the MFE220 unit which was previously expected during May 2026 and the Company will provide further updates in this regard in due course.
The Company also confirms it has been engaged in discussions with certain existing shareholders and prospective new investors regarding a potential equity capital raise to support the next phase of technical and commercial development following completion of the FAT. In light of the incident during testing, these discussions have been paused pending greater technical clarity. As a result, the Company has a constrained working capital position and the Board is actively evaluating potential funding and strategic options to resolve the immediate liquidity requirement.
The Company is reviewing its insurance position in relation to the incident and assessing the potential implications for its commercial arrangements with customers. These discussions and investigations are ongoing and, while the full impact on timing and contractual outcomes remains under review, the Board is focused on establishing a clear path forward and will provide further updates as appropriate.
Due to the ongoing uncertainty regarding the Company's financial position, its current limited working capital and the circumstances noted above, the Company has requested that its shares are suspended from trading on AIM with effect from 7.30 a.m. today.
Commenting, Chief Executive Officer of CPH2, Jon Duffy, said: "This is a disappointing outcome as we approached the final FAT Level 3 testing. However, we will immediately start work towards resolving this technical issue so that we are able to minimise any commercial impact on our business."
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.